Who Is Funding the Science That's Too Early for Venture Capital?
April 22, 2026
Icahn School of Medicine at Mount Sinai
#13 in Universities
13Institution Overview
Overall
Ranking
13
12
Rank in
Research Capabilities
33
Rank in
Entrepreneurial Readiness
13
Rank in
Market Translation
New York, NY
Icahn School of Medicine at Mount Sinai, located in New York, New York, ranks 13th among universities in the Cure Innovation Index. The school places 12th in Research Capabilities and 13th in Market Translation, with a profile balanced between discovery and translation. Its infrastructure includes an MSTP program, a Clinical and Translational Science Award, and faculty-led clinical trials. The school also supports an incubator, biomedical entrepreneurship training, and an MD/MBA dual degree; Entrepreneurial Readiness, where it ranks 33rd, sits below its performance in the other two domains.
Ranking Metrics
Research Capabilities
Icahn School of Medicine at Mount Sinai ranked above average for Research Capabilities, a measure of the foundational infrastructure and resources that enable an institution to conduct high-quality, innovative science. Out of the factors in this category, Icahn School of Medicine at Mount Sinai fared best in Funding Support.
Learn MoreEntrepreneurial Readiness
Icahn School of Medicine at Mount Sinai ranked below average for Entrepreneurial Readiness, a measure of whether the institution has built a supportive ecosystem for entrepreneurship and whether faculty are engaged in and incentivized toward commercial activity. Out of the factors in this category, Icahn School of Medicine at Mount Sinai fared best in Ecosystem Support.
Learn MoreMarket Translation
Icahn School of Medicine at Mount Sinai ranked above average for Market Translation, a measure of how effectively a research institution moves scientific discovery out of the lab and into real-world clinical and commercial applications. Out of the factors in this category, Icahn School of Medicine at Mount Sinai fared best in Health Impact.
Learn More
Cure Innovation Index Methodology
From a pool of more than 6,000 institutions, the top 303 were ranked using two dozen indicators — from scientific foundation and lab infrastructure to patents, products, and partnerships — drawn from more than a dozen federal and commercial databases, an original audit of all institutions, and surveys of more than 3,300+ scientists, industry leaders, and biomedical experts.
Insights From the Cure Innovation Index
Explore by Category
Innovation isn't a single moment — it's an entire ecosystem. The Index evaluates institutions across two dozen indicators, grouped in three core domains that reveal the full picture of what it takes to turn groundbreaking science into real-world impact.
